Amazon's Alexa+ AI assistant is rolling out to all U.S. Amazon Prime subscribers beginning today, with the service available at no additional cost. Amazon says that Prime subscribers can access Alexa+ ...
If you just finished watching the finale of Fallout season two, hopefully, you hung around until the end for its post-credits scene. That’s because within it hides the blueprints for “Liberty Prime ...
New month, new movies and more to watch on Prime Video that we have to tell you all about. Love is in the air as we snuggle closer and closer to Valentine’s Day, which means Prime Video is laying out ...
A new year has begun and, well, it can still feel pretty overwhelming, can’t it? You might need a bit of feel-good escapism. The good news is, there’s quite a lot of that if you look for it. The bad ...
(NEXSTAR) – The second phase of a $2.5 billion settlement over Amazon Prime has begun, giving those who have not yet received a payment a chance to cash in. Last year, Amazon settled with the Federal ...
For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...
To kick off 2026, Amazon Prime members will be able to download 10 more free games starting this month. Over a dozen separate games will be able to stream via Luna cloud delivery as well. Civilization ...
Don't say Amazon never got you anything. As a bit of a Christmas miracle, Prime Video has brought back several add-on subscription streaming deals. Even better, Roku is joining in the fun, so both ...
Prime Video is one of those streamers that we're lucky to get one decent option from each month, but in December we're getting one of its best. Season 2 of the post-apocalyptic drama-comedy Fallout is ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...